Recent advances in the management of cystic fibrosis (CF) target underlying defects in the CF transmembrane conductance regulator (CFTR) protein, but efficacy analyses remain limited to specific genotype–based subgroups. Patient-derived model systems may therefore aid in expanding access to these drugs. Brushed human nasal epithelial cells (HNEs) are an attractive tissue source, but it remains unclear how faithfully they recapitulate human bronchial epithelial cell (HBE) CFTR activity. We examined this gap using paired, brushed HNE/HBE samples from pediatric CF subjects with a wide variety of CFTR mutations cultured at the air-liquid interface. Growth and structural characteristics for the two cell types were similar, including differentiation into mature respiratory epithelia. In electrophysiologic analysis, no correlation was identified between nasal and bronchial cultures in baseline resistance or epithelial sodium channel (ENaC) activity. Conversely, robust correlation was demonstrated between nasal and bronchial cultures in both stimulated and inhibited CFTR activity. There was close correlation in modulator-induced change in CFTR activity, and CFTR activity in both cell types correlated with in vivo sweat chloride measurements. These data confirm that brushed HNE cell cultures recapitulate the functional CFTR characteristics of HBEs with fidelity and are therefore an appropriate noninvasive HBE surrogate for individualized CFTR analysis.
John J. Brewington, Erin T. Filbrandt, F.J. LaRosa III, Jessica D. Moncivaiz, Alicia J. Ostmann, Lauren M. Strecker, John P. Clancy
Title and authors | Publication | Year |
---|---|---|
Elexacaftor/Tezacaftor/Ivacaftor Supports Treatment for CF with ΔI1023-V1024-CFTR
Huang Y, Gonzales Cordova JM, Penrod S, Bendy LL, Cheng PC, Sanders DB, Davis MD, Gaston B, Chmiel JF |
International Journal of Molecular Sciences | 2025 |
Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application
Rubin M, Artusi I, Cozza G |
Frontiers in Pharmacology | 2025 |
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.
Bacalhau M, Camargo M, Lopes-Pacheco M |
Journal of Personalized Medicine | 2024 |
A Fast Scoring of Human Primary Respiratory Epithelia Grown at Air–Liquid Interface (ALI) to Assess Epithelial Morphology in Research and Personalized Medicine Settings
Lutsch CT, Feng L, Gómez Hohn A, Brandt L, Tamm S, Janciauskiene S, Stanke F, Jonigk D, Dittrich AM, Braubach P |
Journal of Personalized Medicine | 2024 |
Cell Culture Differentiation and Proliferation Conditions Influence the In Vitro Regeneration of the Human Airway Epithelium
Redman E, Fierville M, Cavard A, Plaisant M, Arguel MJ, Ruiz Garcia S, McAndrew EM, Girard-Riboulleau C, Lebrigand K, Magnone V, Ponzio G, Gras D, Chanez P, Abelanet S, Barbry P, Marcet B, Zaragosi LE |
American Journal of Respiratory Cell and Molecular Biology | 2024 |
Investigation of CFTR Function in Human Nasal Epithelial Cells Informs Personalized Medicine.
Pion A, Kavanagh E, Joynt AT, Raraigh KS, Vanscoy L, Langfelder-Schwind E, McNamara J, Moore B, Patel S, Merlo K, Temme R, Capurro V, Pesce E, Merlo C, Pedemonte N, Cutting GR, Sharma N |
American journal of respiratory cell and molecular biology | 2024 |
Glypican-3 is a key tuner of the Hedgehog pathway in COPD
Petit LM, Saber Cherif L, Devilliers MA, Hatoum S, Ancel J, Delepine G, Durlach A, Dubernard X, Mérol JC, Ruaux C, Polette M, Deslée G, Perotin JM, Dormoy V |
Heliyon | 2024 |
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.
Salinas DB, Wee CP, Bailey B, Raraigh K, Conrad D |
Annals of the American Thoracic Society | 2023 |
Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and Research
Fawcett LK, Turgutoglu N, Allan KM, Belessis Y, Widger J, Jaffe A, Waters SA |
Journal of Personalized Medicine | 2023 |
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient
Allan KM, Astore MA, Kardia E, Wong SL, Fawcett LK, Bell JL, Visser S, Chen PC, Griffith R, Jaffe A, Sivam S, Vittorio O, Kuyucak S, Waters SA |
Frontiers in Molecular Biosciences | 2023 |
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier.
Lee RE, Reidel B, Nelson MR, Macdonald JK, Kesimer M, Randell SH |
Advanced Drug Delivery Reviews | 2023 |
Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells
Joynt AT, Kavanagh EW, Newby GA, Mitchell S, Eastman AC, Paul KC, Bowling AD, Osorio DL, Merlo CA, Patel SU, Raraigh KS, Liu DR, Sharma N, Cutting GR |
2023 | |
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Oliver KE, Carlon MS, Pedemonte N, Lopes-Pacheco M |
Expert Opinion on Pharmacotherapy | 2023 |
Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis.
Rodenburg LW, Metzemaekers M, van der Windt IS, Smits SMA, den Hertog-Oosterhoff LA, Kruisselbrink E, Brunsveld JE, Michel S, de Winter-de Groot KM, van der Ent CK, Stadhouders R, Beekman JM, Amatngalim GD |
Scientific Reports | 2023 |
Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Otter CJ, Fausto A, Tan LH, Weiss SR, Cohen NA |
Journal of visualized experiments : JoVE | 2023 |
CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor
Karen S Raraigh, Kathleen C Paul, Jennifer L. Goralski, Erin N Worthington, Anna V Faino, Stanley Sciortino, Yiting Wang, Melis A Aksit, Hua Ling, Derek L. Osorio, Frankline M Onchiri, Shivani U Patel, Christian A. Merlo, Kristina Montemayor, Ronald L Gibson, Natalie E West, Amita Thakerar, Robert J Bridges, David N. Sheppard, Neeraj Sharma, Garry Cutting |
JCI Insight | 2022 |
CFTR-mediated monocyte-macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons
Xi Zhang, Camille M. Moore, Laura D Harmacek, Joanne Domenico, Vittobai Rashika Rangaraj, Justin Ideozu, Jennifer R Knapp, Katherine J Woods, Stephanie Jump, Shuang Jia, Jeremy W Prokop, Russell Bowler, Martin J. Hessner, Erwin W. Gelfand, Hara Levy |
JCI Insight | 2022 |
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs
E Sondo, F Cresta, C Pastorino, V Tomati, V Capurro, E Pesce, M Lena, M Iacomino, A Baffico, D Coviello, T Bandiera, F Zara, L Galietta, R Bocciardi, C Castellani, N Pedemonte |
International journal of molecular sciences | 2022 |
A medium composition containing normal resting glucose that supports differentiation of primary human airway cells
R Morgan, C Manfredi, K Easley, L Watkins, W Hunt, S Goudy, E Sorscher, M Koval, S Molina |
Scientific Reports | 2022 |
Established and Novel Human Translational Models to Advance Cystic Fibrosis Research, Drug Discovery, and Optimize CFTR-Targeting Therapeutics
Cholon DM, Gentzsch M |
Current Opinion in Pharmacology | 2022 |
Small molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough
Rhianna E Lee, Catherine A Lewis, Lihua He, Emily C Bulik-Sullivan, Samuel Gallant, Teresa M Mascenik, Hong Dang, Deborah M Cholon, Martina Gentzsch, Lisa Morton, John T Minges, Jonathan W. Theile, Neil A. Castle, Michael Knowles, Adam J Kimple, Scott H. Randell |
Journal of Clinical Investigation | 2022 |
Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect
Wong SL, Awatade NT, Astore MA, Allan KM, Carnell MJ, Slapetova I, Chen PC, Setiadi J, Pandzic E, Fawcett LK, Widger JR, Whan RM, Griffith R, Ooi CY, Kuyucak S, Jaffe A, Waters SA |
American journal of respiratory cell and molecular biology | 2022 |
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
Silva IA, Laselva O, Lopes-Pacheco M |
Journal of Personalized Medicine | 2022 |
Quantifying Intracellular Viral Pathogen: Specimen Preparation, Visualization and Quantification of Multiple Immunofluorescent Signals in Fixed Human Airway Epithelium Cultured at Air-Liquid Interface.
Wong SL, Pandzic E, Kardia E, Allan KM, Whan RM, Waters SA |
Journal of Personalized Medicine | 2022 |
Organotypic sinonasal airway culture systems are predictive of the mucociliary phenotype produced by bronchial airway epithelial cells
Delhove J, Alawami M, Macowan M, Lester SE, Nguyen PT, Jersmann HP, Reynolds PN, Roscioli E |
Scientific Reports | 2022 |
Patient-derived cell models for personalized medicine approaches in cystic fibrosis.
Ramalho AS, Amato F, Gentzsch M |
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022 |
Gene therapy for cystic fibrosis: new tools for precision medicine
JA Lee, A Cho, EN Huang, Y Xu, H Quach, J Hu, AP Wong |
Journal of Translational Medicine | 2021 |
Air−Liquid Interface Cultures of the Healthy and Diseased Human Respiratory Tract: Promises, Challenges, and Future Directions
D Baldassi, B Gabold, OM Merkel |
2021 | |
Large pH oscillations promote host defense against human airways infection
D Kim, J Liao, NB Scales, C Martini, X Luan, A Abu-Arish, R Robert, Y Luo, GA McKay, D Nguyen, MA Tewfik, CD Poirier, E Matouk, JP Ianowski, S Frenkiel, JW Hanrahan |
Journal of Experimental Medicine | 2021 |
A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
JX Jiang, L Wellhauser, O Laselva, I Utkina, Z Bozoky, T Gunawardena, Z Ngan, S Xia, MD Paola, PD Eckford, F Ratjen, TJ Moraes, J Parkinson, AP Wong, CE Bear |
Stem Cell Reports | 2021 |
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis
DE Keegan, JJ Brewington |
International journal of molecular sciences | 2021 |
CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling
JD Anderson, Z Liu, LV Odom, L Kersh, JS Guimbellot |
American journal of physiology. Lung cellular and molecular physiology | 2021 |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
M Calucho, S Gartner, P Barranco, P Fernández-Álvarez, RG Pérez, EF Tizzano |
Scientific Reports | 2021 |
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles
M Comegna, G Conte, AP Falanga, M Marzano, G Cernera, AM Lullo, F Amato, N Borbone, S DErrico, F Ungaro, I dAngelo, G Oliviero, G Castaldo |
Scientific Reports | 2021 |
Breathe—Your immune system is counting on it
NA McCarty |
Journal of Experimental Medicine | 2021 |
Personalized Medicine Based on Nasal Epithelial Cells: Comparative Studies with Rectal Biopsies and Intestinal Organoids
IA Silva, V Railean, A Duarte, MD Amaral |
Journal of Personalized Medicine | 2021 |
Impact of inhaled pollutants on response to viral infection in controlled exposures
ME Rebuli, SA Brocke, I Jaspers |
Journal of Allergy and Clinical Immunology | 2021 |
Partial Decellularized Scaffold Combined with Autologous Nasal Epithelial Cell Sheet for Tracheal Tissue Engineering
LH Dang, SH Hung, Y Tseng, LX Quang, NT Le, CL Fang, H Tseng |
International journal of molecular sciences | 2021 |
Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
MP Dumas, S Xia, CE Bear, F Ratjen |
EBioMedicine | 2021 |
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells
G Sette, SL Cicero, G Blaconà, S Pierandrei, SM Bruno, V Salvati, G Castelli, M Falchi, B Fabrizzi, G Cimino, RD Maria, M Biffoni, A Eramo, M Lucarelli |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2021 |
Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation
E Gecili, W Su, C Brokamp, E Andrinopoulou, F LaRosa, T Pestian, J Clancy, G Solomon, J Brewington, R Szczesniak |
Journal of Cystic Fibrosis | 2021 |
Culture and Imaging of Human Nasal Epithelial Organoids
Liu Z, Anderson JD, Natt J, Guimbellot JS |
Journal of visualized experiments : JoVE | 2021 |
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Guido Veit, Ariel Roldan, Mark A. Hancock, Dillon F. Da Fonte, Haijin Xu, Maytham Hussein, Saul Frenkiel, Elias Matouk, Tony Velkov, Gergely L. Lukacs |
JCI Insight | 2020 |
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
MD Kim, N Baumlin, JS Dennis, M Yoshida, A Kis, C Aguiar, A Schmid, E Mendes, M Salathe |
ERJ Open Research | 2020 |
Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD
R Belgacemi, E Luczka, J Ancel, Z Diabasana, JM Perotin, A Germain, N Lalun, P Birembaut, X Dubernard, JC Mérol, G Delepine, M Polette, G Deslée, V Dormoy |
EBioMedicine | 2020 |
The future of cystic fibrosis care: a global perspective
SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, E Tullis, C Castaños, C Castellani, CA Byrnes, F Cathcart, SH Chotirmall, R Cosgriff, I Eichler, I Fajac, CH Goss, P Drevinek, PM Farrell, AM Gravelle, T Havermans, N Mayer-Hamblett, N Kashirskaya, E Kerem, JL Mathew, EF McKone, L Naehrlich, SZ Nasr, GR Oates, C O'Neill, U Pypops, KS Raraigh, SM Rowe, KW Southern, S Sivam, AL Stephenson, M Zampoli, F Ratjen |
The lancet. Respiratory medicine | 2020 |
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
M Lopes-Pacheco |
Frontiers in pharmacology | 2020 |
Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
DR Laucirica, LW Garratt, A Kicic |
Frontiers in immunology | 2020 |
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
Z Liu, JD Anderson, L Deng, S Mackay, J Bailey, L Kersh, SM Rowe, JS Guimbellot |
Genes & development | 2020 |
Choice of Differentiation Media Significantly Impacts Cell Lineage and Response to CFTR Modulators in Fully Differentiated Primary Cultures of Cystic Fibrosis Human Airway Epithelial Cells
V Saint-Criq, L Delpiano, J Casement, JC Onuora, JH Lin, MA Gray |
Cells | 2020 |
Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models
JK Park, A Shrivastava, C Zhang, BA Pollok, WE Finkbeiner, ER Gibb, NP Ly, B Illek |
Frontiers in Pediatrics | 2020 |
In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells
RE Rayner, J Wellmerling, W Osman, S Honesty, M Alfaro, ME Peeples, E Cormet-Boyaka |
Journal of Cystic Fibrosis | 2020 |
Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis
M Mitroi, D Albulescu, A Capitanescu, A Docea, G Musat, G Mitroi, O Zlatian, A Tsatsakis, G Tzanakakis, D Spandidos, D Calina |
Molecular medicine reports | 2019 |
A marine-sourced fucoidan solution inhibits Toll-like-receptor-3-induced cytokine release by human bronchial epithelial cells
M Dutot, S Grassin-Delyle, H Salvator, M Brollo, P Rat, R Fagon, E Naline, P Devillier |
International Journal of Biological Macromolecules | 2019 |
Ciliated Epithelial Cell Differentiation at Air-Liquid Interface Using Commercially Available Culture Media
Dani Do Hyang Lee, Alina Petris, Robert E Hynds, Christopher O'Callaghan |
Methods in molecular biology (Clifton, N.J.) | 2019 |
Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
NT Awatade, SL Wong, CK Hewson, LK Fawcett, A Kicic, A Jaffe, SA Waters |
Frontiers in pharmacology | 2018 |
Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine
E Matthes, J Goepp, C Martini, J Shan, J Liao, DY Thomas, JW Hanrahan |
Frontiers in pharmacology | 2018 |